Prophylactic intravenous hydroxyethyle starch solution prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: a prospective, randomized, double-blind and placebo-controlled study

By König E   Bussen S   Sütterlin M   Steck T  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2421-2424

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Ovarian hyperstimulation syndrome and benign intracranial hypertension in pregnancy after in-vitro fertilization and embryo transfer: Case report

By Lesny P.  

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 1953-1955

Oxford University Press

Access to resources Recommend Favorite

Case report. Unilateral hydrothorax as a sole and recurrent manifestation of ovarian hyperstimulation syndrome following in-vitro fertilization

By Friedler S   Rachstein A   Bukovsky I   Ron-El R   Raziel A  

Human Reproduction, Vol. 13, Iss. 4, 1998-04 ,pp. : 859-861

Oxford University Press

Access to resources Recommend Favorite

Case report. Critical ovarian hyperstimulation syndrome in a 'coasted' in-vitro fertilization patient

By Tortoriello DV   McGovern PG   Colon JM   Loughlin J   Santoro N  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 3005-3008

Oxford University Press

Access to resources Recommend Favorite

Changes in CA602 and CA546 concentrations in patients during in-vitro fertilization and embryo transfer, and ovarian hyperstimulation syndrome.

By Takamatsu K   Kasuga M   Nakano M   Udagawa Y   Yoshimura Y   Nozawa S  

Human Reproduction, Vol. 12, Iss. 3, 1997-03 ,pp. : 441-445

Oxford University Press

Access to resources Recommend Favorite